Trump Signs Order Narrowing Childhood Vaccine Recommendations

President Donald Trump signed an executive order on August 10, 2026, titled "Delivering Gold Standard Childhood Vaccine Recommendations for Americans," narrowing the vaccines recommended for all children to a list of 11 immunizations and formalizing categories that shift several other vaccines to a shared decision-making model between parents and providers.¹

The order builds on a December 2025 presidential memorandum and a May 2026 executive order that directed the Department of Health and Human Services (HHS) to align the United States schedule with practices in peer countries.¹

What the Order Changes

Under the order, immunizations against measles, mumps, rubella, diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type B, pneumococcal disease, human papillomavirus (HPV), and varicella remain recommended for all children. A second category recommends vaccines for high-risk groups, including respiratory syncytial virus (RSV) monoclonal antibodies, hepatitis A, hepatitis B, meningococcal B, meningococcal ACWY, and dengue.¹

A third category places hepatitis A, hepatitis B, rotavirus, influenza, and COVID-19 vaccines under shared clinical decision-making between families and providers.¹

The order also states that the combined measles, mumps, rubella vaccine should eventually be administered as 3 separate single-disease shots once such products are domestically available and that childhood immunizations should, to the extent feasible, be administered at separate visits rather than combined.¹

It directs the HHS Task Force on Safer Childhood Vaccines to present plans within 90 days on offering single-antigen alternatives to combination vaccines, reassessing vaccine timing and sequencing, developing adjuvants other than aluminum, and improving safety monitoring and transparency.¹

States are advised to review the recommendations when considering school-entry immunization laws, and the US Attorney General is directed to pursue legal action against state laws that conflict with parental authority, religious liberty, and disability-accommodation obligations, including exemptions from immunization requirements.¹

Pharmacy and Provider Implications

The order's changes to core recommendations, combined with continuing uncertainty over the Advisory Committee on Immunization Practices (ACIP), have direct consequences for pharmacy practice, since vaccine administration authority and insurance coverage in many states are tied to the federal immunization schedule.²

In July 2026, the American Pharmacists Association (APhA) and 8 partner pharmacy organizations sent a joint letter to Kennedy raising concerns that a revised ACIP charter overemphasizes vaccine risk and could delay recommendations that pharmacists rely on for scope of practice and billing. The coalition cited 2025-2026 season data showing pharmacies administered 62% of adult influenza vaccines, 96% of RSV vaccines, and 89% of COVID-19 vaccines nationwide and asked HHS to guarantee prompt ACIP review after FDA approvals, minimum annual meetings, and publication of recommendations in the Morbidity and Mortality Weekly Report.³

That request followed an earlier HHS announcement narrowing recommendations for RSV, meningococcal disease, hepatitis A, and hepatitis B vaccines and moving influenza, COVID-19, and rotavirus vaccines to the shared decision-making model HHS has now written into the August 10 order.²

HHS officials at the time pointed to a comparison with Denmark, which recommends vaccination against 10 diseases compared with 18 in the United States as of 2024, though outside researchers cautioned that differences in health care access between the 2 countries limit the comparison.²

AAP Issues Competing Flu Guidance

AAP released its own policy statement and technical report, "Recommendations for Prevention and Control of Influenza in Children, 2026-2027," recommending vaccination for all children 6 months and older without medical contraindications.⁴

The recommendations note that the 2025-2026 season resulted in 190 pediatric deaths and that historically about 85% of children who died of flu were not vaccinated.⁴

"The good news is flu vaccines have been thoroughly studied," Kristina A. Bryant, MD, FAAP, a member of the AAP Committee on Infectious Diseases, said in a news release.⁴

The AAP noted that vaccination coverage remained low last season, with only 49.4% of children ages 6 months through 17 years vaccinated as of May 16, 2026, and cited a CDC-authored study finding that vaccination reduces the risk of pediatric flu death by 80%. The AAP said the CDC has not yet released its own flu vaccine recommendations for the coming season, so the AAP and other medical societies are issuing evidence-based guidance independently. The academy noted flu vaccines are still expected to be covered by commercial insurance and available through the Vaccines for Children program.⁴

The AAP statement also addressed antiviral treatment, recommending it for hospitalized children or those with severe or progressive disease, and noting that baloxavir marboxil (Xofluza) will be available as a generic this season for eligible children 5 years and older, expanding access, though it is not recommended for hospitalized patients.⁴

Ongoing Tension Over Vaccine Policy

The AAP's decision to publish independent guidance is not new. In January 2026, the academy released its annual immunization schedule, explicitly declining to endorse CDC recommendations, the first time it had done so since the 2 organizations pledged in 1993 to maintain a single universal schedule.⁵

"For now, unfortunately, we have to ignore everything about vaccines that is coming from our federal government," Sean O'Leary, MD, MPH, chair of the AAP Committee on Infectious Diseases, said.⁵

AAP President Susan Kressly, MD, FAAP, said the organization would continue publishing its own schedule "developed by experts, guided by science, trusted by pediatricians and families."⁵

REFERENCES

1. Delivering gold standard childhood vaccine recommendations for Americans. Executive order. The White House. August 10, 2026. Accessed August 10, 2026. https://www.whitehouse.gov/presidential-actions/2026/08/delivering-gold-standard-childhood-vaccine-recommendations-for-americans/

2. Nowosielski B. HHS limits vaccine recommendations for childhood schedules. Drug Topics. January 5, 2026. Accessed August 10, 2026. https://www.drugtopics.com/view/hhs-limiting-vaccine-recommendations-for-childhood-schedules

3. Gallagher A. Pharmacy groups urge HHS to restore confidence in vaccine advisory process. Drug Topics. July 16, 2026. Accessed August 10, 2026. https://www.drugtopics.com/view/pharmacy-groups-urge-hhs-to-restore-confidence-in-vaccine-advisory-process

4. American Academy of Pediatrics issues recommendations for influenza prevention and control for 2026-27. News release. American Academy of Pediatrics. August 10, 2026. Accessed August 10, 2026. https://www.aap.org/en/news-room/news-releases/aap/2026/american-academy-of-pediatrics-issues-recommendations-for-influenza-prevention-and-control-for-2026-27/

5. Nowosielski B. AAP releases updated childhood vaccine schedule amid recent HHS overhaul. Drug Topics. January 28, 2026. Accessed August 10, 2026. https://www.drugtopics.com/view/aap-releases-updated-childhood-vaccine-schedule-amid-recent-hhs-overhaul